NCT01993576View on ClinicalTrials.gov

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Breast Cancer.
Interventions
DRUG

Indocyanine Green

Intravenous injection of 0.25 mg/kg Indocyanine Green (ICG) before the surgery

Trial Locations (1)

B-1000

Jules Bordet Insitute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER